About Envision Healthcare (NYSE:EVHC)
Envision Healthcare Holdings, Inc., formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc. (EmCare) and American Medical Response, Inc. (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States. Its AMR segment has developed a network of ambulance services and other healthcare transportation services in the United States. It provides Emergency Department (ED) physician services to hospitals and other facilities. Its hospitalist services include inpatient physician services. It provides anesthesiology services to hospitals, free-standing ambulatory surgery centers and physician offices. It provides radiology, including tele-radiology services to hospitals. It offers management, oversight and surgeon staffing for trauma surgery services.
Industry, Sector and Symbol
Industry Long-Term Care Facilities
Trailing P/E Ratio-7.612
Forward P/E Ratio15.09
Sales & Book Value
Annual Sales$4.59 billion
Price / Sales0.99
Cash Flow$2.17 per share
Price / Cash17.37
Book Value$39.44 per share
Price / Book0.96
Return on Equity4.88%
Return on Assets2.02%
Envision Healthcare (NYSE:EVHC) Frequently Asked Questions
What is Envision Healthcare's stock symbol?
Envision Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVHC."
How will Envision Healthcare's stock buyback program work?
Envision Healthcare declared that its board has initiated a share repurchase program on Tuesday, September 19th 2017, which allows the company to buyback $250,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 4.5% of its shares through open market purchases. Shares buyback programs are often a sign that the company's management believes its stock is undervalued.
How were Envision Healthcare's earnings last quarter?
Envision Healthcare Co. (NYSE:EVHC) posted its earnings results on Tuesday, October, 31st. The company reported $0.73 EPS for the quarter, missing analysts' consensus estimates of $0.81 by $0.08. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. Envision Healthcare's quarterly revenue was up 142.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.13 earnings per share. View Envision Healthcare's Earnings History.
When will Envision Healthcare make its next earnings announcement?
Where is Envision Healthcare's stock going? Where will Envision Healthcare's stock price be in 2018?
15 brokers have issued 12-month price objectives for Envision Healthcare's stock. Their forecasts range from $31.00 to $77.00. On average, they expect Envision Healthcare's share price to reach $39.82 in the next year. View Analyst Ratings for Envision Healthcare.
What are Wall Street analysts saying about Envision Healthcare stock?
Here are some recent quotes from research analysts about Envision Healthcare stock:
- 1. Cantor Fitzgerald analysts commented, "Increasing 2018 estimates and updating PT. We are increasing our 2018 adjusted EPS estimate to $3.95 from $3.40 to reflect a lower corporate tax rate that adds $0.57 to adjusted EPS, offset by changes in the timing and estimated net proceeds from the AMR divestiture, which is now expected to close in 1Q18. Our adjusted 2018 EBITDA estimate remains $982 million, but our new price target reflects higher free cash flow from the lower taxes, and incremental margin improvements from reduced overhead labor costs." (1/5/2018)
- 2. According to Zacks Investment Research, "Envision Healthcare's stock has outperformed the industry in last one month. The company has taken some discrete actions which are expected to improve its operating performance and realize $50 million of incremental adjusted EBITDA in 2018. It is optimistic about the physician services market, which is witnessing consolidation. Also the divestiture of its AMR business will help the company to focus on its core operations. The company is aggressively shifting its payor contract to in-network from out of network which will lead to greater client and patient satisfaction, competitive differentiation, administrative efficiency, enhanced collections and an accelerated cash flow. But, it suffers from high indebtedness, consequently leading to an increase in the interest ratio. Also, its operating expense is on the rise and is exceeding the revenue growth to have exerted pressure on the operating margins." (1/2/2018)
- 3. Jefferies Group LLC analysts commented, "Investors have been anticipating a volume-driven FY17 guidance miss for the last few months, as evidenced by the discount in its valuation, so last night's guidance shortfall, while wider than expectations, does not come as a surprise. We remain Buy-rated given our view that EVHC's fundamentals are intact; guidance is reasonable/conservative; valuation is compelling, and AMR sale could drive incremental share upside." (3/1/2017)
Who are some of Envision Healthcare's key competitors?
Some companies that are related to Envision Healthcare include Jazz Pharmaceuticals (JAZZ), WellCare Health Plans (WCG), William Demant Hol (WILYY), Steris (STE), Neurocrine Biosciences (NBIX), Bio-Rad Laboratories (BIO), Beigene (BGNE), West Pharmaceutical Services (WST), Stada Arzneimittel (STDAF), Icon (ICLR), United Therapeutics (UTHR), Catalent (CTLT), Dr.Reddy's Laboratories (RDY), PRA Health Sciences (PRAH), athenahealth (ATHN), Hill-Rom (HRC), MEDNAX (MD) and BIO-TECHNE (TECH).
Who owns Envision Healthcare stock?
Envision Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Maverick Capital Ltd. (8.27%), BlackRock Inc. (6.64%), Guggenheim Capital LLC (1.64%), Geode Capital Management LLC (1.12%), Vaughan Nelson Investment Management L.P. (1.05%) and Sapience Investments LLC (0.93%). Company insiders that own Envision Healthcare stock include John Thomas Gawaluck and Robert Jon Coward. View Institutional Ownership Trends for Envision Healthcare.
Who sold Envision Healthcare stock? Who is selling Envision Healthcare stock?
Envision Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Jefferies Group LLC, TIAA CREF Investment Management LLC, Raymond James & Associates, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Employees Retirement System of Texas, Wells Fargo & Company MN and Eaton Vance Management. View Insider Buying and Selling for Envision Healthcare.
Who bought Envision Healthcare stock? Who is buying Envision Healthcare stock?
Envision Healthcare's stock was bought by a variety of institutional investors in the last quarter, including Maverick Capital Ltd., Guggenheim Capital LLC, Sapience Investments LLC, Douglas Lane & Associates LLC, State of Tennessee Treasury Department, BlackRock Inc., Silver Rock Financial LP and Deutsche Bank AG. View Insider Buying and Selling for Envision Healthcare.
How do I buy Envision Healthcare stock?
Shares of Envision Healthcare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Envision Healthcare's stock price today?
One share of Envision Healthcare stock can currently be purchased for approximately $37.73.
How big of a company is Envision Healthcare?
Envision Healthcare has a market capitalization of $4.56 billion and generates $4.59 billion in revenue each year. The company earns $-18,600,000.00 in net income (profit) each year or ($5.00) on an earnings per share basis. Envision Healthcare employs 65,200 workers across the globe.
How can I contact Envision Healthcare?
Envision Healthcare's mailing address is 1A BURTON HILLS BOULEVARD, NASHVILLE TN, 37215. The company can be reached via phone at 615-665-1283 or via email at [email protected]
MarketBeat Community Rating for Envision Healthcare (EVHC)MarketBeat's community ratings are surveys of what our community members think about Envision Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Envision Healthcare (NYSE:EVHC) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.60||2.60||2.73||3.00|
|Ratings Breakdown: ||0 Sell Rating(s)|
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
5 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
|0 Sell Rating(s)|
1 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
|Consensus Price Target: ||$39.82||$38.64||$45.85||$71.75|
|Price Target Upside: ||10.68% upside||10.66% upside||56.74% upside||41.05% upside|
Envision Healthcare (NYSE:EVHC) Consensus Price Target History
Envision Healthcare (NYSE:EVHC) Analyst Ratings History
(Data available from 2/21/2016 forward)
Envision Healthcare (NYSE:EVHC) Earnings History and Estimates Chart
Envision Healthcare (NYSE EVHC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/31/2017||Q3 2017||$0.81||$0.73||$2.03 billion||$1.99 billion||View||N/A|
|8/7/2017||Q2 2017||$0.75||$0.79||$1.96 billion||$1.95 billion||View||Listen|
|5/2/2017||Q1 2017||$0.69||$0.69||$2.52 billion||$1.88 billion||View||Listen|
|2/28/2017||Q416||$1.20||$1.08||$1.41 billion||$1.39 billion||View||Listen|
|11/1/2016||Q316||$0.36||$0.36||$1.67 billion||$1.64 billion||View||N/A|
|8/2/2016||Q216||$0.36||$0.34||$1.66 billion||$1.64 billion||View||N/A|
|5/3/2016||Q1||$0.25||$0.28||$1.55 billion||$1.60 billion||View||N/A|
|2/24/2016||Q415||$0.35||$0.35||$1.45 billion||$1.48 billion||View||Listen|
|11/3/2015||Q3 2015||$0.91||$0.99||$643.74 million||$650.23 million||View||N/A|
|10/22/2015||Q315||$0.39||$0.30||$1.41 billion||$1.37 billion||View||Listen|
|8/4/2015||Q215||$0.35||$0.37||$1.30 billion||$1.35 billion||View||Listen|
|5/5/2015||Q115||$0.26||$0.26||$1.19 billion||$1.24 billion||View||N/A|
|2/25/2015||Q414||$0.36||$0.36||$1.16 billion||$1.16 billion||View||N/A|
|11/4/2014||Q314||$0.33||$0.35||$1.13 billion||$1.15 billion||View||N/A|
|7/31/2014||Q214||$0.25||$0.28||$1.04 billion||$1.08 billion||View||N/A|
|4/22/2014||Q114||$0.19||$0.20||$1.02 billion||$1.01 billion||View||N/A|
|3/5/2014||Q413||$0.17||$0.20||$994.41 million||$984.80 million||View||N/A|
|2/25/2014||Q4 2013||$0.57||$0.60||$282.97 million||$284.57 million||View||N/A|
|11/13/2013||Q3 13||$0.13||$0.13||$950.22 million||$955.90 million||View||N/A|
|10/22/2013||Q3 2013||$0.53||$0.53||$265.62 million||$268.23 million||View||N/A|
|7/23/2013||Q2 2013||$0.55||$0.58||$266.01 million||$269.34 million||View||N/A|
|4/23/2013||Q1 2013||$0.52||$0.52||$261.36 million||$260.06 million||View||N/A|
Envision Healthcare (NYSE:EVHC) Earnings Estimates
2018 EPS Consensus Estimate: $3.07
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Envision Healthcare (NYSE:EVHC)
No dividend announcements for this company have been tracked by MarketBeat.com
Envision Healthcare (NYSE EVHC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.10%
Envision Healthcare (NYSE EVHC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|7/3/2017||Robert Jon Coward||Insider||Sell||1,500||$62.69||$94,035.00||97,863|| |
|6/22/2017||Robert Jon Coward||Insider||Sell||1,500||$60.00||$90,000.00||99,363|| |
|5/3/2017||Robert Jon Coward||Insider||Sell||1,500||$60.53||$90,795.00||114,363|| |
|4/3/2017||Robert Jon Coward||Insider||Sell||1,500||$61.34||$92,010.00||115,863|| |
|3/10/2017||John Thomas Gawaluck||Director||Buy||1,500||$66.65||$99,975.00||6,080|| |
|3/1/2017||Robert Jon Coward||Insider||Sell||1,500||$65.00||$97,500.00||104,319|| |
|10/5/2015||Leonard M Riggs Jr||Director||Sell||4,000||$36.24||$144,960.00||32,179|| |
|9/15/2015||Randel G Owen||CFO||Sell||20,000||$42.00||$840,000.00||367,683|| |
|9/14/2015||William A. Sanger||CEO||Sell||175,000||$41.06||$7,185,500.00|| |
|8/17/2015||Randel G Owen||CFO||Sell||140,000||$44.22||$6,190,800.00|| |
|8/17/2015||Todd G Zimmerman||CEO||Sell||180,000||$44.21||$7,957,800.00|| |
|7/6/2015||Leonard M Riggs Jr||Director||Sell||4,000||$39.32||$157,280.00|| |
|6/25/2015||Dighton Packard||Insider||Sell||40,000||$40.00||$1,600,000.00|| |
|4/20/2015||Dighton Packard||Insider||Sell||240,188||$39.44||$9,473,014.72|| |
|4/16/2015||Horne Edward Van||Insider||Sell||10,000||$40.00||$400,000.00|| |
|4/16/2015||William A Sanger||CEO||Sell||418,500||$40.00||$16,740,000.00|| |
|4/13/2015||Craig A Wilson||SVP||Sell||18,600||$39.57||$736,002.00|| |
|4/13/2015||Leonard M Riggs Jr||Director||Sell||4,000||$39.57||$158,280.00|| |
|3/19/2015||Horne Edward Van||Insider||Sell||12,000||$38.00||$456,000.00|| |
|3/19/2015||Randel G Owen||CFO||Sell||50,000||$38.04||$1,902,000.00|| |
|3/16/2015||Richard J Schnall||Director||Buy||100,000||$36.73||$3,673,000.00|| |
|3/9/2015||Steven G Murphy||SVP||Sell||12,021||$36.03||$433,116.63|| |
|2/25/2015||William A Sanger||CEO||Sell||153,782||$37.50||$5,766,825.00|| |
|2/23/2015||William A Sanger||CEO||Sell||7,100||$37.54||$266,534.00|| |
|1/9/2015||William A Sanger||CEO||Sell||194,968||$37.52||$7,315,199.36|| |
|1/8/2015||Randel G Owen||CFO||Sell||200,000||$36.56||$7,312,000.00|| |
|10/31/2014||Randel G Owen||CFO||Sell||19,180||$35.00||$671,300.00|| |
|10/28/2014||Randel G Owen||CFO||Sell||30,820||$35.00||$1,078,700.00|| |
|10/24/2014||Todd G Zimmerman||CEO||Sell||125,000||$35.00||$4,375,000.00|| |
|10/22/2014||Horne Edward Van||Insider||Sell||6,540||$35.00||$228,900.00|| |
|10/6/2014||Horne Edward Van||Insider||Sell||10,200||$35.00||$357,000.00|| |
|10/1/2014||Horne Edward Van||Insider||Sell||10,606||$34.67||$367,710.02|| |
|9/29/2014||Dighton Packard||Insider||Sell||32,400||$34.97||$1,133,028.00|| |
|9/29/2014||Michael L Smith||Director||Sell||7,000||$34.97||$244,790.00|| |
|9/29/2014||Randel G Owen||CFO||Sell||150,000||$34.97||$5,245,500.00|| |
|9/29/2014||Steve W Ratton Jr||EVP||Sell||25,000||$34.97||$874,250.00|| |
|9/29/2014||William A Sanger||CEO||Sell||200,000||$34.97||$6,994,000.00|| |
|9/15/2014||Steven G Murphy||SVP||Sell||45,988||$34.75||$1,598,083.00|| |
|7/16/2014||Horne Edward Van||Insider||Sell||20,269||$32.90||$666,850.10|| |
|7/16/2014||Leonard M Riggs Jr||Director||Sell||15,000||$32.90||$493,500.00|| |
|7/16/2014||Randel G Owen||CFO||Sell||249,375||$32.90||$8,204,437.50|| |
|7/16/2014||Steve W Ratton Jr||EVP||Sell||42,948||$32.90||$1,412,989.20|| |
|7/16/2014||Steven G Murphy||SVP||Sell||21,852||$32.90||$718,930.80|| |
|7/16/2014||William A Sanger||CEO||Sell||543,900||$32.90||$17,894,310.00|| |
|8/19/2013||Leonard M Riggs Jr||Director||Buy||44,000||$23.00||$1,012,000.00|| |
|8/19/2013||Steven G Murphy||SVP||Buy||5,000||$23.00||$115,000.00|| |
Envision Healthcare (NYSE EVHC) News Headlines
Envision Healthcare (NYSE:EVHC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Envision Healthcare (NYSE:EVHC) Income Statement, Balance Sheet and Cash Flow Statement
Envision Healthcare (NYSE EVHC) Stock Chart for Wednesday, February, 21, 2018